Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

No Longer King Of The North, Pfizer Looks To Recapture Crown
Forbes
Wednesday, April 30, 2014 - 1:03pm
tags:
Pfizer, M&A
Members of Parliament to grill Pfizer chiefs over bid for AstraZeneca
Independent, UK
Wednesday, April 30, 2014 - 1:01pm
tags:
M&A, UK, Pfizer, AstraZeneca
Synergy Pharmaceuticals' plecanatide shows positive results in Phase 2B study
Yahoo/Fly on the Wall
Wednesday, April 30, 2014 - 12:58pm
tags:
Synergy Pharmaceuticals, plecanatide, IBS-C
Surveying the therapeutic areas pharma participates in on facebook, YouTube and Pinterest
Cutting Edge Info
Wednesday, April 30, 2014 - 12:56pm
tags:
social media
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala
Seeking Alpha
Wednesday, April 30, 2014 - 12:50pm
tags:
melanoma, Bristol-Myers Squibb, Roche, Merck, Amgen
Regeneron chief outranks every other biopharma CEO with $36M in 2013 pay
Fierce Pharma
Wednesday, April 30, 2014 - 12:39pm
tags:
Regeneron, executive pay
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Wednesday, April 30, 2014 - 12:37pm
tags:
Gilead Sciences, Teva Pharmaceuticals, Copaxone, Idelalisib, Bristol-Myers Squibb, nivolumab, Cyramza, Eli Lilly, Pfizer, palbociclib, Sovaldi
Stymied by Meda, deal-hungry Mylan could jump on Stada or Mallinckrodt
Fierce Pharma
Wednesday, April 30, 2014 - 12:31pm
tags:
Stada, Meda, Mylan, Mallinckrodt, M&A
GSK says staying on sidelines in Astra, Pfizer fight
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:39am
tags:
GSK, M&A, Pfizer, AstraZeneca
Pfizer's post-megamerger cost-cutting record? 51,500 jobs in 7 years
Fierce Pharma
Wednesday, April 30, 2014 - 10:33am
tags:
Pfizer, layoffs, M&A, restructuring, Wyeth, Merck, Schering Plough
Sources: Bayer offers animal health biz, cash for Merck's OTC unit
Fierce Pharma
Wednesday, April 30, 2014 - 10:32am
tags:
Bayer, OTC, Merck, animal health, M&A, consumer health
Drugs That Will Help Johnson & Johnson Grow By 5% In 2014
Forbes
Wednesday, April 30, 2014 - 10:28am
tags:
JNJ, Remicade, Olysio, Velcade, Zytiga
Teva's abuse-resistant painkiller succeeds in study
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:25am
tags:
painkillers, Teva Pharmaceuticals, CEP-33237, hydrocodone, abuse-resistant painkillers
Shire says new dry-eye drug fails to meet trial goal
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:23am
tags:
Shire, dry eye disease, Lifitegrast
FDA weighs risks of approving Singulair as over-the-counter allergy medication
Yahoo/AP
Wednesday, April 30, 2014 - 10:22am
tags:
Singulair, FDA, OTC, Merck
Incorrect biopsy results cloud Nymox Pharma prostate cancer study
Yahoo/Reuters
Wednesday, April 30, 2014 - 10:21am
tags:
Nymox, prostate cancer, NX-1207
TB Drug Fighting Resistant Strains Wins Europe Approval
Bloomberg
Wednesday, April 30, 2014 - 8:59am
tags:
TB, Europe, Otsuka, Deltyba, tuberculosis
GW Pharma's Marijuana Drug Could Treat Autism
TheStreet.com
Wednesday, April 30, 2014 - 8:49am
tags:
Medical Marijuana, GW Pharma, Sativex, autism, Marinol, Solvay
GlaxoSmithKline drug sales off to weak start in first quarter
Yahoo/Reuters
Wednesday, April 30, 2014 - 8:46am
tags:
GSK, earnings
[video]Will These 3 Drugs Keep AbbVie's Future Bright After Humira?
Motley Fool
Wednesday, April 30, 2014 - 8:44am
tags:
Humira, AbbVie, hepatitis C, Neurocrine Biosciences, endometriosis, Elagolix, Parkinson's Disease, levodopa-carbidopa intestinal gel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.